Demonstration of the "no-reflow" phenomenon by digital coronary arteriography.
نویسندگان
چکیده
6. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington rondomized trio1 of intracoronory streptokinase in acute myocordiol infarction. N Engl J Med 1983;309:1477-1482. 7. Schuler G. Schwarz F, Hofmann M, Mehmel H, Manthey J, Maurer W, Rauch B, Herrmann HJ, Kubler W. Thrombolysis in acute myocordiol injarction using intracoronary streptokinose: assessment by thallium-201 scintigraphy. Circulation 1982;66:658-664. 8. Schrodcr R, Xnr&u G. “on ierrner no, Lmderer T, Bruggemann T, Heitz J, Vohringer HF. Wegscheider K. Intravenous short-term infusion of streptokinose in acute myocardial infarction. Circulation 1983;67:536-548. 9. Neuhaus KL, Tebbe V, Sauer G, Kreuzer H, Kostering H. High dose intravenous streptokinose in acute myocordiol infarction. Clin Cordial 1983;6:426-434. 10. Spann JF. Sherry S. Carabello BA, Mann RH. McCann WD, Gault JH. Gentzler RD, Rosenberg KM, Maurer AH, Denenberg B.S. Warner HF, Rubin RN, Malmud LS, Comerota A. High-dose, brief intravenous streptokinnse early in acuze myocardiol infarction. Am Heart J 1982;104:939-945. 11. Reduto LA, Smalling RW, Freund CC. Gould KL. Intracoronory infusion ojstreptokinase in patients with acute myocordiol infarction: effects ojreperfusion on left ventricular performance. Am J Cordial 1981;48:403-409. 12. Simoons ML, Wijns W, Balakumaran K. Serruys PW. van den Brand M. Fioretti P, Reiber JHC, Lie P, Hugenholtz PG. The effect of introcoronary thrombolysis with streptokinase on myocordiof thallium distribution and left ventricular junction assessed by blood-pool scintigrophy. Eur Heart J 19&2;3:433-440. 13. Hooghoudt TEH, Serruys PW. Reiber JMC, Slager CJ, van den Brand M, Hugenholtz PG. The effect of reconalizotion of the occluded coronary artery in acute myocordial infarction on left ventricular junction. Eur Heart J ’ 1982;3:416-421. 14. Spann JF, Sherry S. Carabello BA. Denenberg BS, Mann RH, McCann WD, Gault JH, Gentzler RD. Belber AD, Maurer AH, Cooper EM. Coronary thrombofysis by intravenous streptokinose in acute myocordiol infarction: acute and follow-up studies. Am J Cordial 1984;53:655-663. 15. Rrmllhg RW, Fxs:c; 1 _, :vLdibaws MW, Freund GC, Hicks CH, Reduto LA, Walker WE, Sterling RP, Gould KL. Sustoined improvement in left ventriculor junction and mortality by intracoronory streptokinase administration during evolving myocordiol infarction. Circulation 1983;68:131-138. 16. Rentrop P, Blanke H, Karsch KR, Rutsch W, Schartl M, Merx W, Dorr R, Mathey D, Kuck K. Chonges in left ventricular junction after intracoronory streptokinose infusion in clinically evolving myocordial infarction. Am Heart J 1981;102:1188-1193. 1’7. Schroder R. Systemic verses introcoronary streptokinase infusion in the treatment of acute myocardinl injorction. JACC 1983;1:1254-1261. 16. Serruys PW, Wijns W, van den Brand M, Ribeiro V, Fioretti P. Simoons ML, Kooijman CJ. Reiber JHC. Hugenholtz PG. Is transluminal coronary angioplasty mandatory after successful thrombolysis? Br Heart J 1983;50:257-265. 19. Merx W, Dorr R. Rentrop P, Blanke H, Karsch KR, Mathey DG. Kremer P. Rutsch W, Schmutzler H. Evaluation of the effectiveness of intracoronary streptokinose infusion in acute myocardiol infarction: postprocedure monogement and hospitol course in 204 patients. Am Heart f 1981:102:1181-3187, 20. DeWood MA, Spores J, Hensley GR, Simpson CS, Eugster GS. Sutherland KI, Grunwald RP, Shields JP. Coronary orteriographic findings in acute tronsmural myocardiol infarction. Circulation 1983:68:suppI 1:1-39-I-49.
منابع مشابه
No-Reflow Phenomenon in Patients with ST-Elevation Acute Myocardial Infarction, Treated with Primary Percutaneous Coronary Intervention: A Study of Predictive Factors
Introduction: No-reflow phenomenon in coronary vessels, manifested in some patients with reperfused acute myocardial infarction (MI), is associated with poor clinical and functional outcomes. Therefore, evaluation of predisposing risk factors can be helpful in risk assessment and identification of patients at higher risk. Herein, we aimed to study the predictive factors for the development of...
متن کاملPlatelet-To-Lymphocyte Ratio as a Predictor of No-Reflow after Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis
Introduction: No-reflow increases the complications and mortality rate of primary percutaneous coronary intervention (PCI). Therefore, it is important to identify patients at a higher risk of developing no-reflow. This study aimed to systematically review the prognostic value of the platelet-to-lymphocyte ratio (PLR) to predict no-reflow. Materials and Methods:</s...
متن کاملNo-reflow phenomenon.
To the Editor: In reviewing no-reflow, Rezkalla and Kloner1 indicted injuryinduced microvascular changes, but did not mention spasm of resistance vessels, which might be the basic mechanism of no-reflow. I proposed in 1971 that no-reflow (“stasis”) is due to ischemic injury-induced spasm, and the evidence seemed convincing.2 Short coronary occlusions reversed no-reflow, and this was interpreted...
متن کاملThe coronary no-reflow phenomenon: a review of mechanisms and therapies.
The phenomenon of no-reflow is defined as inadequate myocardial perfusion through a given segment of the coronary circulation without angiographic evidence of mechanical vessel obstruction. Temporary occlusion of the artery, a prerequisite condition for no-reflow, may be produced in the experimental setting or occur during reperfusion of an infarct-related artery or following percutaneous coron...
متن کاملRenal Dysfunction on Admission Predicts No-Reflow Phenomenon in Patients Undergoing Manual Thrombus Aspiration during Primary Percutaneous Coronary Intervention.
BACKGROUND No-reflow is a frequent complication during percutaneous coronary intervention (PCI) for acute ST segment elevation myocardial infarction (STEMI). Available data is limited regarding its impact on short-term outcomes in patients undergoing manual thrombus aspiration. Renal impairment is also associated with higher complication rates in STEMI. Herein, we aimed to evaluate the impact o...
متن کاملAngiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.
OBJECTIVES We sought to elucidate the long-term prognostic importance of angiographic no-reflow phenomenon after percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial infarction (AMI). BACKGROUND Angiographic no-reflow phenomenon, a reduced coronary antegrade flow (Thrombolysis in Myocardial Infarction [TIMI] flow grade < or =2) without mechanical obstruction after recana...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The American journal of cardiology
دوره 57 1 شماره
صفحات -
تاریخ انتشار 1986